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PURPOSE. The process of photoreceptor cell death in retinitis pigmentosa is still not well
characterized, and identification of common mechanisms will be instrumental for
development of therapeutic strategies. Here we investigated activation of Bax in rd1, P23H
transgenic, and Rho knockout retinas.
METHODS. Bax activation was evaluated by immunofluorescence using anti-activated Bax-
specific antibodies and by Western blotting on mitochondrial protein extracts. Knockdown of
cathepsin D, calpain 1, and calpain 2 was achieved by short hairpin RNA (shRNA) delivery in
rd1 mutant photoreceptors cells differentiated from retinal neurospheres. The mechanism of
Bax activation through calpains was evaluated in vivo by intravitreal injection of calpastatin.
RESULTS. We defined activation and mitochondrial localization of Bax as well as activation of
calpains and cathepsin D in the three models of retinitis pigmentosa. Taking advantage of an
in vitro culture system for rd1 mutant photoreceptors, we unraveled the mechanism of Bax
activation. We demonstrated that calpain 1 and cathepsin D contributed to activation of Bax
and to apoptosis-inducing factor (Aif) nuclear translocation. In vivo interference with calpain
activity blocks Bax activation in the rd1 and Rho knockout retinas and reduces activation in
the P23H transgenic retina.
CONCLUSIONS. Activation of Bax was observed in all three models of retinitis pigmentosa and
leads to neurodamage by localization at the mitochondrion. Our data suggest that Bax can be
envisaged as one of the promising target molecules for restraining photoreceptor
degeneration.
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Cell death is largely regulated by the Bcl2 family ofinteracting proteins. In mammalian cells this family of
proteins is divided into three main subfamilies: prosurvival
members such as Bcl2 and BclXL; apoptotic Bax members
including Bax and Bak; and apoptotic BH3-only members such
as Bim, Bik, and Puma. The decision whether to live or die is
often influenced by interactions among these proteins and by
their relative intracellular concentration.1 Bax and Bak play
central roles in apoptosis because after their activation they
oligomerize at the mitochondrial outer membrane, causing its
breaching and the release of apoptogenic factors including
cytochrome c and Smac/Diablo. Whereas Bak shows constitu-
tive mitochondrial localization, Bax is cytosolic in healthy cells
and translocates to mitochondria after activation in response to
apoptotic signals. Prosurvival Bcl2 normally inhibits Bax
activation by direct binding, but the consequences of Bax/
Bcl2 interaction are still under investigation.2 Furthermore, Bax
localization to the mitochondrial membrane is associated with
cell death but does not necessarily cause mitochondrial outer
membrane permeabilization and cytochrome c release.2
Several animal models are available for the study of retinitis
pigmentosa (RP). We previously characterized the molecular
mechanism leading to photoreceptor cell death in the rd1
murine model bearing a loss of function of the photo-
transduction enzyme phosphodiesterase 6b (Pde6b). We
demonstrated that influx of calcium ions into photoreceptor
cells activates calpains. Calpains are proteases that cleave
mitochondrial apoptosis-inducing factor (Aif) that exits from
the mitochondrion and translocates to the nucleus, playing a
fundamental role in rod cell death.3 Calpains appear to have a
central role in the mutant rd1 retina because degeneration
could be restrained by exposure of the retina to calpain
blockers.3,4 We previously showed that in rd1 mutant rods,
activation of calpains regulates subsequent mitochondrial
release of Aif.3 In different cellular systems, it has been
reported that Aif is cleaved by calpains and its exit from
mitochondria requires Bax, but not Bak.5–7 Bax itself can be
activated by calpains and/or cathepsin D, which are activated in
rd1 degenerating rods.8,9
Previous studies showed very limited involvement of
caspase 3 in the rd1 mutant retina,10 although activation of
effector caspases as well as calpains could be observed in a
different model of RP expressing P23H mutant rhodopsin.11,12
On the other hand, no information is available concerning the
molecular mechanisms of cell death in retinas lacking
rhodopsin expression.
The purpose of this study was to define if Bax is activated in
three murine models of retina degeneration and to evaluate
whether active Bax participates in retinal degeneration in vivo.
Secondly, we defined the mechanism of Bax activation in the
rd1 model, taking advantage of the availability of an in vitro cell
system for molecular studies of this mutation. Our data
confirmed that Bax is activated in the degenerating retina and
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that a protease cascade mediates its activation. We finally show
that Bax activation requires calpains in vivo.
METHODS
Animal Care and Treatments
All procedures on mice were conducted at Centro Servizi
Stabulario Interdipartimentale, were approved by the Ethical
Committee of University of Modena and Reggio Emilia (Prot. N.
50 12/03/2010) and by Italian Ministero della Salute, and were
in accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research. C3H/HeN (rd1), 129sv,
and C57BL6J mice were purchased from Harlan Italy (Udine,
Italy). Rhodopsin P23H transgenic mice (P23HTg)13 were
kindly provided by T. Dryja. Rhodopsin knockout mice14 were
bred on the 129sv genetic background. Mice were maintained
in 12-hour light/dark cycles. For intravitreal administration,
mice were anesthetized with an intraperitoneal injection of 2
mL/100 g body weight avertin (1.25% [wt/vol] 2,2,2-tribromo-
ethanol and 2.5% [vol/vol] 2-methyl-2-butanol; Sigma, Milan,
Italy). Subsequently, 0.5 lL calpastatin peptide (200-lM
solution with an expected final concentration in the eye of
20 lM; Calbiochem, Milan, Italy) was delivered intravitreously
via a transscleral transchoroidal approach. Control eyes
received vehicle only. Treated mice were killed 16 hours post
injection.
Retinal Neurosphere Culture and Differentiation
Retinal neurospheres from adult wild-type and rd1 mice were
isolated and cultured as previously described.15 Retinal neuro-
spheres were plated on extracellular matrix (Sigma)-coated
coverslips, differentiated with 1% fetal bovine serum, and then
processed for immunohistochemical analysis. Differentiation
into rod-like cells was assessed by staining with anti-rhodopsin
antibodies (1D4 and RetP1; Sigma) as previously described.16
For short hairpin RNA (shRNA) studies, cells were treated with
retroviruses expressing different shRNAs at the fifth day of
differentiation in the presence of polybrene. Spontaneous
apoptosis in rd1 mutant cells but not in wild-type cells was
activated after 11 days in vitro. We performed all immunoflu-
orescence analyses at this time point, and the data shown
derived from the analysis of four slides from two independent
experiments.
RNA Interference (RNAi)
Sequences beginning with an AA dinucleotide were chosen in
the Bax, Calpain 1 (Capn1), Calpain 2 (Capn2), and
Cathepsin D (Ctsd) mRNA, and we designed hairpin RNAi
template oligonucleotides (shRNA). The control shRNA was
generated from scramble sequences not targeting any known
gene. Sequences targeted by shRNAs are listed in Supplemen-
tary Table S1. Retroviruses from pSUPER.retro.puro vector
(OligoEngine, Seattle, WA, USA) expressing the different RNAi
were prepared by transient transfection in ecotropic Phoenix-
ECO packaging cells (ATCC, Rockville, MD, USA). Efficiencies
of shRNAs were checked by infection of NIH3T3 (ATCC) cells
followed by Western blotting.
DNA Nick-End Labeling by TUNEL and
Immunofluorescence
Eyes were fixed, embedded in paraffin, and sectioned as
previously described.3 Photoreceptors differentiated from
retinal neurospheres were fixed in 4% paraformaldehyde.
Apoptotic nuclei were detected by TdT-mediated dUTP
terminal nick-end labeling kit (TUNEL, fluorescein; Roche,
Milan, Italy) according to the producer’s protocols. Primary
antibodies used were as follows: anti-Aif (1:100; Sigma), anti-
active Bax 6A7 (recognizes the N-term exposed after activation
but not phosphorylated Bax,17 1:200; Millipore, Milan, Italy),
anti-Cathepsin D (1:100; Santa Cruz Biotechnology, Heidelberg,
Germany), anti-Calpain 1 (1:100; Calbiochem). Secondary
antibodies were Oregon Green 488 anti-goat, Alexa Fluor 568
anti-mouse and anti-rabbit antibodies (Molecular Probes,
Monza, Italy). Slides were mounted with Mowiol 4-88 (Sigma)
and analyzed at an Axioskop 40 fluorescence microscope
(Zeiss, Arese, Italy).
Calpain Activity Assay
Cryosections from unfixed retinas or differentiated cells grown
on coverslips were incubated for 15 minutes in calpain
reaction buffer (CRB: 25 mM HEPES-KOH pH 7.2, 65 mM
KCl, 2 mM MgCl2, 1.5 mM CaCl2, 2 mM dithiothreitol) and then
exposed for 1 hour at 378C to the fluorescent calpain substrate
CMAC, t-BOC-Leu-Met (A6520; Invitrogen, Monza, Italy) at a
final concentration of 2 lM. Slides were washed twice for 10
minutes each in CRB, mounted with Mowiol 4-88, and analyzed
at an Axioskop 40 fluorescence microscope (Zeiss) using the
filter excitation/emission 365/420.
Real-Time Quantitative PCR
Total RNA was extracted with TRIzol reagent (Life Technologies,
Monza, Italy), and cDNA was synthesized using Transcriptor
High Fidelity cDNA Synthesis Kit (Roche). Real-time PCR was
carried out with the GeneAmp 7000 Sequence Detection
System (Applied Biosystems, Milan, Italy). Primers used are
listed in Supplementary Table S2. Quantification results were
expressed in terms of cycle threshold (Ct). All real-time
quantitative PCR reactions were run in triplicate, and the Ct
values were averaged. The S26 PCR product was used as
reference marker, and data were derived from the formula 2DCt.
Retinal Protein Extracts and Western Blotting
Analysis
Retinas were lysed in cold lysis buffer (50 mM Tris-HCl pH 7.4,
150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 1 mM EDTA, 1 mM
Na3VO4, protease inhibitor cocktail from Sigma) and incubated
30 minutes on ice. Tissue was disrupted with 40 strokes and
centrifuged at 900g for 5 minutes at 48C. For mitochondrial-
enriched extracts, tissue was homogenized in 220 mM D-
mannitol, 70 mM sucrose, 20 mM HEPES-KOH pH 7.2, 1 mM
EDTA, 0.1% BSA, 1 mM Na3VO4, protease inhibitor cocktail
(Sigma) and centrifuged at 500g for 10 minutes at 48C. The low-
speed supernatant was centrifuged at 10,000g for 10 minutes
at 48C. The resulting mitochondrial pellet was resuspended in
washing buffer (250 mM sucrose, 20 mM HEPES-KOH pH 7.4, 1
mM EDTA, 1 mM Na3VO4, protease inhibitor cocktail) and
centrifuged at 10,000g for 10 minutes at 48C. The final
mitochondrial pellet was resuspended in respiration buffer
(250 mM sucrose, 50 mM HEPES pH 7.4, 10 mM KH2PO4, 2
mM MgCl2, 1 mM EDTA, 1 mM Na3VO4, protease inhibitor
cocktail). The purity of enriched lysates was checked by
Western blotting analysis with a mitochondrial marker (anti-
cytochrome c, 1:2000; BD Biosciences, Milan, Italy) or a
cytosol marker (anti-pan-actin, 1:3000; Millipore).
Equivalent amounts of protein extracts (50 lg) were used
for Western blot analysis. The antibodies used for Western
blotting were anti-Bax 6A7 (1:2000; Millipore), anti-Bcl2
(1:2000; Cell Signaling, Milan, Italy), anti-Calpain 1 (1:1000;
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Chemicon, Segrate, Italy), anti-Calpain 2 (1:3000; Abcam,
Cambridge, UK), and anti-Cathepsin D (C-20 1:1000; Santa
Cruz Biotechnology). Quantification was performed by densi-
tometry analysis of scanned images using ImageJ software
(National Institutes of Health, Bethesda, MD, USA), corrected
by background, and plotted as protein/normalizing protein.
Data are means 6 SD of three blots with proteins derived from
three animals from two biological replicates.
Statistical Analysis
Real-time PCR data, cell counts, and densitometry analyses are
shown as mean 6 SD. Paired t-test analysis was performed
comparing data derived from at least three different wild-type
to at least three different mutant retinas.
RESULTS
Activation of Bax in Three Murine Models of
Retinitis Pigmentosa
To characterize activation of Bax and other BH3 family
members related to cell death, we analyzed expression at the
mRNA levels and compared each mutant retina to the wild-type
control matched for age. During degeneration (postnatal day
[P]11) in the rd1 retina3 we observed a significant increase of
proapoptotic Bax transcripts and decrease of prosurvival Bcl2
mRNA but no change in Bak (Fig. 1A). Similar results were
obtained when we analyzed the P23HTg retina at the peak of
cell death (P9)13 (Fig. 1B), confirming a recent study in a rat
model.18 Upregulation of Bax but not of Bak was observed
also in the Rho/ retina at the peak of rod cell death (P45)14
but, differently from what occurred in the other models, Bcl2
was upregulated (Fig. 1C). We confirmed increase of Bax
protein (Supplementary Fig. S1) and Bax activation using
antibodies recognizing the activated form of Bax. We
specifically detected activated Bax in the photoreceptor cell
inner segment only in the degenerating mutant retinas (Figs.
1D–F, Supplementary Fig. S3). Activation of Bax requires a
conformational change with exposure of a hydrophobic
domain to allow Bax localization to the mitochondrial
membrane. We therefore analyzed Bax localization at the
mitochondria by Western blotting on mitochondrial-enriched
protein extracts. We confirmed Bax translocation to the
mitochondria in response to cell death stimuli in the rd1,
P23HTg, and Rho/ mutant retinas (Figs. 1G–I). Bax could
otherwise not be detected in mitochondria extracts from wild-
type retinas at all the different stages that we examined.
We also assessed if Bcl2 was downregulated at the protein
level. We could confirm a significant reduction of Bcl2 in
protein extracts from rd1 and P23HTg retinas (Figs. 1J, 1K).
Bcl2 mRNA levels in the Rho/ mutant retina were upregu-
lated but not Bcl2 protein (Fig. 1L), suggesting that other Bcl2
family members may regulate Bcl2 at the protein level, as
previously demonstrated in T-cells.19 Bcl2 reduction does not
appear to be a common event in retinal degeneration. Bax
activation in the degenerating retina may thus require other
factors aside from loss of interaction with Bcl2.
Activation of Calpains and Cathepsin D in Three
Murine Models of Retinitis Pigmentosa
We previously reported activation of calpains in the rd1
retina.3,4 Using this in situ technique we assessed activation of
calpains also in P23HTg retinas at the age of 10 days and in
Rho/ retinas at the age of 45 days. We could detect calpain
activity in the photoreceptor cell layer in the three models of
RP but not in wild-type controls (Figs. 2A–C). By double
labeling with the fluorescent calpain substrate and TUNEL, we
determined that active calpains colabeled approximately 70%
of cells undergoing cell death in rd1 and Rho/mutant retinas
and 50% in P23HTg retinas (Fig. 2D, Supplementary Fig. S2).
FIGURE 1. Bax activation during photoreceptor cell death. (A–C) Real-
time PCR analysis of Bcl2, Bax, and Bak mRNA on P11 wild-type and
rd1 retinas (A); on P10 wild-type and P23HTg retinas (B); and on P45
wild-type and Rho/ retinas (C). In the mutant retinas (black bars), we
detected significant upregulation of Bax mRNA compared to wild-type
retinas (white bars). Downregulation of Bcl2 mRNA was observed in
rd1 and P23HTg retinas (A, B). Upregulation of Bcl2 mRNA was
observed in Rho/ retinas (C). Values of wild-type samples were set at
1; n¼ 3. Student’s t-test, **P  0.01, *P  0.05. (D–F) Activation of Bax
was detected with the activated Bax-specific antibody at the inner
segment (arrows) of P11 rd1 (D), P10 P23HTg (E), and P45 Rho/ (F)
retinas but not of wild-type retinas. Nuclei are stained in blue with 40,6-
diamidino-2-phenylindole (DAPI). White vertical lines indicate the
layer of photoreceptor nuclei. Scale bar: 10 lm. (G–I) Western blotting
of Bax protein in mitochondria-enriched protein extracts from P11 rd1
(G), P10 P23HTg (H), and P45 Rho/ (I) retinas and matched wild-type
controls. Normalization was performed with anti-cytochrome c
antibodies (lower). (J–L) Western blotting of Bcl2 in total protein
extracts from P11 rd1 (J), P10 P23HTg (K), P45 Rho/ (L), and the
corresponding wild-type controls. Normalization was performed with
anti-actin antibodies (lower). Representative Western blot (top) and
quantification by densitometry (bottom) are shown. Molecular weights
are shown in kDa; n¼ 3. is, inner segment (containing photoreceptor
cytoplasm and mitochondria); onl, outer nuclear layer; opl, outer
plexiform layer; inl, inner nuclear layer.
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Calpain activation therefore strongly correlated with cell death
in rd1 and Rho/ mice. Calpains can directly activate Bax or
activate other proteases, such as cathepsin D, to trigger
activation of Bax.7 We thus assessed cathepsin D activation
by Western blotting. In the rd1 retina we confirmed activation
of cathepsin D by the observation of a significant increase of
the 32-kDa cathepsin D active form (Figs. 2E, 2H). Similar
results were obtained analyzing protein extracts from P23HTg
retinas at the age of 10 days and from Rho/ retina at the age
of 45 days (Figs. 2F–H).
Taken together, these data suggested that Bax was activated
in the three models of RP and that at the time of its stimulation
two classes of proteases, calpains and cathepsin D, were also
active.
Bax Is Activated Through Cathepsin D and
Calpains in rd1 Mutant Photoreceptors
We previously validated an in vitro model for the study of rod
cell death caused by mutations in Pde6b.3 This in vitro model is
based on the generation of retinal neurospheres from rd1 eyes
and differentiation of retinal neurospheres into rod photore-
ceptors.15 In the in vitro model we could detect calcium
influx, calpain activation, and Aif and caspase 12 nuclear
translocation correlating to cell death, similarly to the in vivo
rd1 retina.3 We took advantage of this in vitro system to
molecularly characterize Bax activation in rd1 mutant photo-
receptors. The in vitro model allowed us to knock down
cathepsin D by shRNAs. We tested two shRNAs targeting
different regions of CathD mRNA (Supplementary Table S1),
and we used a retroviral system to allow 100% transduction of
photoreceptor cells, as previously reported.3 Both shRNAs
were very efficient in downregulation of cathepsin D as
demonstrated at the protein level by Western blotting (Fig. 3A).
We observed that knockdown of cathepsin D did not affect
calpain activity but blocked Bax activation. Loss of cathepsin D
could also protect from cell death (Figs. 3B, 3C).
FIGURE 2. Calpain and cathepsin D activation during photoreceptor
cell death. (A–C) We investigated calpain activity by exposure of frozen
nonfixed sections to a fluorescent calpain substrate and detected
several cells with high calpain activity (fluorescent spots in the outer
nuclear layer, arrows) in mutant retinas but no calpain activity in the
corresponding wild-type retinas. White vertical lines indicate the layer
of photoreceptor cells. Scale bars: 10 lm. (D) Histogram representing
the percentage of cells showing calpain activation among the cells
undergoing cell death (TUNELþ). In the rd1 and Rho/ retinas,
approximately 70% of the dying cells activate calpain; in the P23HTg
retina, only 50%; n¼ 3. (E–G) Western blotting of cathepsin D in total
protein extracts from P11 rd1 (E), P10 P23HTg (F), P45 Rho/ (G), and
the corresponding wild-type controls. The antibody recognizes both
cathepsin D (pro-C-D) and activated cathepsin D (actC-D). Normaliza-
tion was performed with anti-actin antibodies (lower). Molecular
weights are shown in kDa. (H) Quantification by densitometry of
Western blotting shown in (E–G). A significant increase of activated
cathepsin D (white bars) was observed in the three models of retinal
degeneration; n ¼ 3. Student’s t-test, ***P  0.001, **P  0.01
comparing activated cathepsin D in mutant and wild-type samples.
FIGURE 3. Cathepsin D regulates activation of Bax in rd1 dying
photoreceptors. (A) NIH3T3 cells were infected with retroviruses
expressing two shRNAs targeting Cathepsin D mRNA (Cath shRNA) or
with a retrovirus expressing an shRNA that recognizes a scrambled
sequence (scrambled shRNA). Western blotting was performed on total
protein extracts from infected NIH3T3 cells and normalized with anti-
actin antibodies (lower). (B) Downregulation of Cathepsin D in rod-like
cells in vitro differentiated from retinal neurospheres. Data represent
percentages of positive cells labeled by immunofluorescence; n ¼ 5.
Similar results were obtained with a second shRNA targeting a different
region of Cathepsin D mRNA. (C) Representative immunofluorescence
images of data shown in (B). Cathepsin D and TUNEL are shown in
green, activated Bax in red; nuclei are stained in blue with DAPI.
Calpain activity was investigated by exposure of cells to a blue
fluorescent calpain substrate visible in cells treated with a control
shRNA as well as with an shRNA targeting Cathepsin D, suggesting that
Cathepsin D does not affect calpain activity. No DAPI staining was
performed on slides treated with calpain substrate. Scale bar for all
figure parts is shown at upper left and is 50 lm.
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Our previous studies showed that in vivo treatment with
calpastatin, an inhibitor of calpain 1 and calpain 2, had
protective effects in the rd1 retina,4 thus suggesting that either
calpain 1 or calpain 2 might be involved in activation of Bax. To
define in more detail which calpain was involved in Bax
activation, we downregulated expression of the two calpains
in the cell culture model. We designed shRNAs that were
specific to knock down either Calpain 1 or Calpain 2 as
shown by Western blot analysis (Figs. 4A, 4B). Knockdown of
calpain 1, known to be the Aif activating calpain, inhibited Bax
activation, Aif nuclear translocation, and cell death (Figs. 4C,
4E). Otherwise knockdown of Calpain 2 had no significant
effect on Bax activation and cell death but could prevent
caspase 12 nuclear translocation, known to be regulated by
Calpain 220 (Fig. 4D).
In vitro differentiated rd1 mutant photoreceptors allowed
us to determine that calpain 1 and cathepsin D are both
involved in Bax activation during photoreceptor cell death, and
that activated Bax is likely to promote Aif nuclear translocation
as reported in other cell types.5–7
Calpains Trigger Bax Activation in Three Models of
Retinitis Pigmentosa
We finally wanted to determine the interrelationship among
these proteases and Bax and to understand if the molecular
pathway unraveled in vitro was activated also in vivo in the
degenerating retina. We injected in vivo P10 rd1 or P9 P23HTg
or P44 Rho/ degenerating eyes with calpastatin, an inhibitor
of calpains. We confirmed the ability of calpastatin to interfere
with calpain activation (Figs. 5A–C, bottom; Supplementary
Fig. S2). Calpastatin was not able to completely abolish calpain
activity in rd1 retinas, as we previously reported4; a similar
result was observed in P23HTg retinas, but a significant
reduction could be confirmed in both mutants (Student’s t-
test, P  0.001) (Figs. 5A, 5B, bottom; Supplementary Fig. S2).
Calpastatin was otherwise very efficient in blocking calpain
activity of Rho/ retinas (Fig. 5C, bottom; Supplementary Fig.
S2). Interference with calpain activity using calpastatin was
able to reduce Bax activation in the three models of RP (Figs.
5A–C, top). Calpastatin was very efficient in blocking Bax in
rd1 and Rho/ mutant retinas but less efficient in P23HTg
retinas, where a decreased but clear staining of activated Bax
could be detected.
To determine if cathepsin D was downstream to calpain in
vivo as shown in vitro, we analyzed cathepsin D activation by
Western blotting in retinas after calpastatin treatment and
found that blocking calpain activity significantly reduced
cathepsin D activation in the treated retinas (Figs. 5D–G).
Interference with cathepsin D activation was more prominent
in the rd1 and Rho/ mutant retinas (Figs. 5D, 5F, 5G).
To confirm that Bax is downstream to calpains and plays an
important role in cell death in the rd1 mutant photoreceptors,
we used the in vitro cell system of rd1 mutant rod-like cells and
downregulated Bax by shRNAs (Figs 5H, 5I). Downregulation
of Bax interfered with cell death as defined by TUNEL staining,
as well as Aif activation as defined by nuclear translocation of
Aif (Fig. 5I). Bax knockdown did not affect calpain activation in
in vitro differentiated rd1 mutant rods (Fig. 5I).
Altogether these data support a model in which Bax is
activated through calpains and cathepsin D in degenerating rod
photoreceptors.
DISCUSSION
In this study we demonstrated that Bax is activated in three
different models of RP. The mechanism of photoreceptor cell
death is still not well characterized, but some common
pathways such as activation of calpains had been described
while others appear to be specific to RP caused by particular
mutations.11 Specifically, while apoptosis is normally associat-
ed with caspase activation and chromatin fragmentation, rod
cell death is characterized by chromatin fragmentation but
effector caspases are activated only in some models of RP. For
instance, cell death in the rd1 mutant retina is not much
affected by caspase 3, while caspases appear to play an
important role in retinas expressing mutant rhodopsin.10–12
Bax and Bak activation can lead to caspase initiation, but Bax
mitochondrial localization does not necessarily trigger mito-
chondrial outer membrane permeabilization.2 Calpain 1 and
Bax downregulation experiments in this study suggest that in
the rd1 mutant photoreceptors, Bax activation is otherwise
FIGURE 4. Calpain 1 but not Calpain 2 regulates activation of Bax in
rd1 dying photoreceptors. (A, B) NIH3T3 cells were infected with
retroviruses expressing shRNAs targeting Calpain 1 mRNA (Calpain 1
shRNA), shRNAs targeting Calpain 2 mRNA (Calpain 2 shRNA), or a
retrovirus expressing an shRNA recognizing a scrambled sequence
(scrambled shRNA). Western blotting for Calpain 1 (A) and Calpain 2
(B) was performed on total protein extracts from infected NIH3T3 cells
and normalized with anti-actin antibodies (lower). (C) Downregulation
of Calpain 1 mRNA by shRNA in rod-like cells in vitro differentiated
from retinal neurospheres. Data represent percentages of positive cells
labeled by immunofluorescence; n ¼ 6. Similar results were obtained
with a second shRNA targeting a different region of Calpain 1 mRNA.
(D) Downregulation of Calpain 2 mRNA by shRNA in rod-like cells in
vitro differentiated from retinal neurospheres. Data represent percent-
ages of positive cells labeled by immunofluorescence; n ¼ 3. Similar
results were obtained with a second shRNA targeting a different region
of Calpain 2 mRNA. (E) Representative images of data shown in (C).
Calpain 1 is shown in green, and activated Bax is shown in red. Nuclear
localization of Aif (red) and TUNEL staining (green) are indicated by
arrows. Scale bar for all figure parts is shown at upper left and is 20
lm.
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linked to Aif, a death activator that exits from the mitochondria
and translocates to the nucleus, as described for other forms of
neuronal degeneration.21
Our study indicates that the mechanisms by which Bax
connects to retinal neurodamage in vivo requires two types of
proteases. The molecular mechanisms of Bax activation have
not been well characterized; but in this study we showed that
in photoreceptor cells, Bax is activated by a protease cascade
involving calpain 1 and cathepsin D. Bax needs to undergo
conformational changes that can be promoted by several
molecules, for example, tBid and cathepsin D, and pH
modifications.8,22 The mechanism of Bax activation by
cathepsin D is still unknown, but cathepsin D has been
suggested to possibly degrade a cytosolic chaperone that
sequesters Bax.8 We cannot exclude the possibility that in the
retina Bax is influenced also by other factors such as changes in
pH. Tafani and colleagues22 showed that changes of intracel-
lular pH interfered with Bax mitochondrial translocation.
Changes of pH in the rd1 mutant retina may be due to
ceramide, which was previously found to induce intracellular
alkalinization23 and to be linked to cell death in retina
degeneration Pde6b mutant mice.24 A similar mechanism was
reported in glioma cells, where lysosomal accumulation of
ceramide induced apoptosis mediated by cathepsin D activa-
tion and Bax insertion into the mitochondrial membrane.25
Loss of binding to prosurvival members of the Bcl2 family may
also affect Bax activation, and we have shown that Bcl2 is
reduced in two of the studied models and specifically the
models with fastest degeneration. This observation suggests
that the protease pathways may play a prevalent role in Bax
activation in the degenerating retina but that Bcl2 downregu-
lation may be required in more severe forms of degeneration.
The in vivo treatments with calpastatin confirmed that
calpains regulate Bax activation through cathepsin D. The
incomplete interference with Bax activation in the P23HTg
retina could be explained by the failure of calpastatin to
completely block calpain activity. A second explanation is the
mechanism of cell death in P23HTg mice that involves calpain
but also caspases, as previously reported; this may activate
multiple pathways of Bax activation in this model of RP.11,12 We
in fact observed correlation of cell death (TUNEL-positive cells)
and calpain activity only in 50% of P23H mutant photorecep-
tors. While calpastatin was able to strongly inhibit Bax
activation in rd1 mutant mice, it reduced but did not stop
cell death.4 This observation suggests that in vivo inhibition of
Bax may not be sufficient to completely block degeneration, as
previously suggested in rd1 mice in which Bax was knocked
out.26
FIGURE 5. Calpains regulate activation of Bax and cathepsin D in vivo.
(A–C) Representative images of immunofluorescence analysis of
retinas after mock intravitreal injection or injection of calpastatin in
P11 rd1 (A), P10 P23HTg (B), and P45 Rho/ (C) mice. Upper parts of
figure are stained with an activated Bax-specific antibody (red), and
nuclei are stained in blue with DAPI. Lower parts of figure are images
of calpain activity assay (blue). Vertical white lines indicate the layer of
photoreceptor cells; n ¼ 3. Scale bar for all figure parts is shown at
upper left (A) and is 10 lm. (D–F) Western blotting of cathepsin D in
total protein extracts from P11 rd1 (D), P10 P23HTg (E), and P45
Rho/ (F) either mock injected or injected with calpastatin (CS). The
antibody recognizes both cathepsin D (46 kDa) and activated cathepsin
D (32 kDa). Normalization was performed with anti-actin antibodies
(lower). Molecular weights are shown in kDa. (G) Quantification by
densitometry of Western blotting shown in (D–F). A significant
decrease of activated cathepsin D (white bars) was observed after
injection of calpastatin (CS); n ¼ 3. Student’s t-test, ***P  0.001
comparing activated cathepsin D in mock and calpastatin-treated
samples. (H) NIH3T3 cells were infected with retroviruses expressing
two shRNAs targeting Bax mRNA (Bax shRNA) or with a retrovirus
expressing an shRNA recognizing a scrambled sequence (scrambled
shRNA). Western blotting was performed on total protein extracts from
infected NIH3T3 cells and normalized with anti-actin antibodies
(lower). (I) Downregulation of Bax mRNA by shRNA in rod-like cells
in vitro differentiated from retinal neurospheres. Representative images
of cells labeled by immunofluorescence; n ¼ 3. Similar results were
obtained with a second shRNA targeting a different region of Bax
mRNA. Activated Bax is shown in red; nuclear localization of Aif
(green) and TUNEL staining (green) are indicated by arrows. DAPI
staining of nuclei is shown in blue. Right: Calpain activity assay in
which cells were exposed to a blue fluorescent calpain substrate
visible in cells treated with a control shRNA as well as with an shRNA
targeting Bax, suggesting that Bax activation does not affect calpain
activity. No DAPI staining was performed on slides treated with calpain
substrate. Scale bar for all parts of the figure is shown at upper left and
is 20 lm.
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Finally, cathepsin D is likely to act downstream to calpains
in experiments conducted in vitro, as its downregulation
completely inhibited Bax activation in presence of active
calpains. We could not test cathepsin D inhibition in vivo and
address this question because treatment with pepstatin A, an
inhibitor of cathepsin D, had toxic effects when injected in the
retina, as previously reported also by other researchers.9
In conclusion, we have demonstrated that Bax is activated
during retinal degeneration in three models of RP and that its
activation is regulated by calpains and cathepsin D in rd1 and
Rho/ photoreceptors. Bax is only partially regulated by this
cascade of proteases in dominant mutations of Rho, and other
factors probably related to endoplasmic reticulum stress may
affect Bax in this model of RP. Altogether these findings suggest
that Bax activation should be evaluated when new therapeutic
approaches are being developed to restrain retina degeneration.
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